Subscribe RSS FeedHealthDay – THURSDAY, Dec. 10 (HealthDay News) — Adding chemotherapy to
standard cancer-suppressing tamoxifen can boost survival in postmenopausal
women with the most common type of breast cancer, known as estrogen
receptor-positive, and it’s best given before the tamoxifen regimen
starts, according to a new study.
Tags: Breast Cancer, Breast Cancer Patients, Cancer Survival, Chemo, Chemotherapy, Estrogen Receptor, Postmenopausal Women, Regimen, Tamoxifen, Type Of Breast Cancer
